Abstract:It is important to characterize the temporal trajectories of disease-related biomarkers in order to monitor progression and identify potential points of intervention. These are especially important for neurodegenerative diseases, as therapeutic intervention is most likely to be effective in the preclinical disease stages prior to significant neuronal damage. Neuroimaging allows for the measurement of structural, functional, and metabolic integrity of the brain at the level of voxels, whose volumes are on the order of mm(3). These voxelwise measurements provide a rich collection of disease indicators. Longitudinal neuroimaging studies enable the analysis of changes in these voxelwise measures. However, commonly used longitudinal analysis approaches, such as linear mixed effects models, do not account for the fact that individuals enter a study at various disease stages and progress at different rates, and generally consider each voxelwise measure independently. We propose a multivariate nonlinear mixed effects model for estimating the trajectories of voxelwise neuroimaging biomarkers from longitudinal data that accounts for such differences across individuals. The method involves the prediction of a progression score for each visit based on a collective analysis of voxelwise biomarker data within an expectation-maximization framework that efficiently handles large amounts of measurements and variable number of visits per individual, and accounts for spatial correlations among voxels. This score allows individuals with similar progressions to be aligned and analyzed together, which enables the construction of a trajectory of brain changes as a function of an underlying progression or disease stage. We apply our method to studying cortical β-amyloid deposition, a hallmark of preclinical Alzheimer's disease, as measured using positron emission tomography. Results on 104 individuals with a total of 300 visits suggest that precuneus is the earliest cortical region to accumulate amyloid, closely followed by the cingulate and frontal cortices, then by the lateral parietal cortex. The extracted progression scores reveal a pattern similar to mean cortical distribution volume ratio (DVR), an index of global brain amyloid levels. The proposed method can be applied to other types of longitudinal imaging data, including metabolism, blood flow, tau, and structural imaging-derived measures, to extract individualized summary scores indicating disease progression and to provide voxelwise trajectories that can be compared between brain regions.

A model of brain morphological changes related to aging and Alzheimer's disease from cross-sectional assessments

A deformation-based morphometry framework for disentangling Alzheimer's disease from normal aging using learned normal aging templates

Exploring Brain Age Calculation Models Available for Alzheimer's Disease

Longitudinal Changes in Surface Based Brain Morphometry Measures in Amnestic Mild Cognitive Impairment and Alzheimer's Disease

Anatomy-Guided Surface Diffusion Model for Alzheimer's Disease Normative Modeling

Alzheimer's Disease Modelling and Staging through Independent Gaussian Process Analysis of Spatio-Temporal Brain Changes

Distinguishing Healthy Ageing from Dementia: a Biomechanical Simulation of Brain Atrophy using Deep Networks

Prediction of the progression of subcortical brain structures in Alzheimer's disease from baseline

MRI‐based axis‐referenced morphometric model corresponding to lamellar organization for assessing hippocampal atrophy in dementia

Longitudinal Volumetric Study for the Progression of Alzheimer's Disease from Structural MRI

Structural progression of Alzheimer’s disease over decades: the MRI staging scheme

MR-based Spatiotemporal Anisotropic Atrophy Evaluation of Hippocampus in Alzheimer's Disease Progression by Multiscale Skeletal Representation.

Personalizing progressive changes to brain structure in Alzheimer's disease using normative modeling

A multivariate nonlinear mixed effects model for longitudinal image analysis: Application to amyloid imaging

TADM: Temporally-Aware Diffusion Model for Neurodegenerative Progression on Brain MRI

Morphometric Analysis of Hippocampus and Lateral Ventricle Reveals Regional Difference Between Cognitively Stable and Declining Persons

Cortical folding correlates to aging and Alzheimer's Disease's cognitive and CSF biomarkers

Bidirectional Modeling and Analysis of Brain Aging with Normalizing Flows

Patterns of structure-function association in normal aging and in Alzheimer's disease: Screening for mild cognitive impairment and dementia with ML regression and classification models

IMAGING MICROSCOPIC NEUROPATHOLOGY OF ALZHEIMER’S DISEASE USING MRI: FROM MODEL SYSTEMS TO HUMAN IN VIVO

Multimodal biological brain age prediction using magnetic resonance imaging and angiography with the identification of predictive regions